标题
Triple-negative breast cancer: investigating potential molecular therapeutic target
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 19, Issue 1, Pages 55-75
出版商
Informa Healthcare
发表日期
2014-10-13
DOI
10.1517/14728222.2014.970176
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Expression of class 3 semaphorins and their receptors in human breast neoplasia
- (2015) Carolyn A Staton et al. HISTOPATHOLOGY
- Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1)
- (2015) Kristen M. Reipas et al. Oncotarget
- Efficacy of biological agents in metastatic triple-negative breast cancer
- (2014) Annalisa Bramati et al. CANCER TREATMENT REVIEWS
- Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario
- (2014) M. Bonotto et al. ONCOLOGIST
- Synthetic Lethal Screens as a Means to Understand and Treat MYC-Driven Cancers
- (2014) S. Cermelli et al. Cold Spring Harbor Perspectives in Medicine
- Non-Pegylated Liposomal Doxorubicin-Cyclophosphamide in Sequential Regimens with Taxanes as Neoadjuvant Chemotherapy in Breast Cancer Patients
- (2014) Patrizia Vici et al. Journal of Cancer
- Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
- (2013) B. Gerber et al. ANNALS OF ONCOLOGY
- c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer
- (2013) S. Kashiwagi et al. BRITISH JOURNAL OF SURGERY
- The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation
- (2013) Gabriel Leprivier et al. CELL
- Lessons from the Cancer Genome
- (2013) Levi A. Garraway et al. CELL
- MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer
- (2013) Yu Jin Kim et al. INTERNATIONAL JOURNAL OF CANCER
- Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial
- (2013) David Cameron et al. LANCET ONCOLOGY
- Aurora-A Identifies Early Recurrence and Poor Prognosis and Promises a Potential Therapeutic Target in Triple Negative Breast Cancer
- (2013) Jie Xu et al. PLoS One
- HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells
- (2013) Sandeep N. Shah et al. PLoS One
- RB1 Status in Triple Negative Breast Cancer Cells Dictates Response to Radiation Treatment and Selective Therapeutic Drugs
- (2013) Tyler J. W. Robinson et al. PLoS One
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy
- (2012) Rainer Girgert et al. BREAST CANCER RESEARCH AND TREATMENT
- Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer
- (2012) Jabed Iqbal et al. HISTOPATHOLOGY
- High Expression of MicroRNA-210 is an Independent Factor Indicating a Poor Prognosis in Japanese Triple-negative Breast Cancer Patients
- (2012) T. Toyama et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
- (2012) Chen Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor-derived microvesicles: The metastasomes
- (2012) Reza Ghasemi et al. MEDICAL HYPOTHESES
- Emerging Roles of Angiopoietin-like 4 in Human Cancer
- (2012) Ming Jie Tan et al. MOLECULAR CANCER RESEARCH
- Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
- (2012) D. W. Craig et al. MOLECULAR CANCER THERAPEUTICS
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
- (2012) Harry D. Bear et al. NEW ENGLAND JOURNAL OF MEDICINE
- MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma
- (2012) K Boll et al. ONCOGENE
- CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes
- (2012) M Niemelä et al. ONCOGENE
- BRCA2 Mutations and Triple-Negative Breast Cancer
- (2012) Peter Meyer et al. PLoS One
- Targeting p90 Ribosomal S6 Kinase Eliminates Tumor-Initiating Cells by Inactivating Y-Box Binding Protein-1 in Triple-Negative Breast Cancers
- (2012) Anna L. Stratford et al. STEM CELLS
- Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence
- (2012) José R. Rossari et al. Journal of Oncology
- Src: a potential target for the treatment of triple-negative breast cancer
- (2011) D. Tryfonopoulos et al. ANNALS OF ONCOLOGY
- Signal transduction by vascular endothelial growth factor receptors
- (2011) Sina Koch et al. BIOCHEMICAL JOURNAL
- Abstract 612: FOXO1A is a target for HER2 overexpressing breast tumors
- (2011) Yanyuan Wu et al. CANCER RESEARCH
- HB-EGF and PDGF Mediate Reciprocal Interactions of Carcinoma Cells with Cancer-Associated Fibroblasts to Support Progression of Uterine Cervical Cancers
- (2011) T. Murata et al. CANCER RESEARCH
- Exploiting synthetic lethal interactions for targeted cancer therapy
- (2011) H. Christian Reinhardt et al. CELL CYCLE
- RB1 and p53 at the crossroad of EMT and triple-negative breast cancer
- (2011) Zhe Jiang et al. CELL CYCLE
- p73 as a Pharmaceutical Target for Cancer Therapy
- (2011) Andrea Bisso et al. CURRENT PHARMACEUTICAL DESIGN
- Semaphorin–plexin signalling genes associated with human breast tumourigenesis
- (2011) P.N. Gabrovska et al. GENE
- MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development
- (2011) Holger Heyn et al. INTERNATIONAL JOURNAL OF CANCER
- Global Expression Analysis Identified a Preferentially Nerve Growth Factor-induced Transcriptional Program Regulated by Sustained Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (ERK) and AP-1 Protein Activation during PC12 Cell Differentiation
- (2011) Steven Mullenbrock et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer
- (2011) D. G. Evans et al. JOURNAL OF MEDICAL GENETICS
- YB-1 evokes susceptibility to cancer through cytokinesis failure, mitotic dysfunction and HER2 amplification
- (2011) A H Davies et al. ONCOGENE
- Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
- (2011) Bin Bao et al. PLoS One
- High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells
- (2011) J. Daniel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chromosome Segregation Errors as a Cause of DNA Damage and Structural Chromosome Aberrations
- (2011) A. Janssen et al. SCIENCE
- Functional Viability Profiles of Breast Cancer
- (2011) R. Brough et al. Cancer Discovery
- Subcellular Localization of Activated AKT in Estrogen Receptor- and Progesterone Receptor-Expressing Breast Cancers
- (2010) Sunil Badve et al. AMERICAN JOURNAL OF PATHOLOGY
- Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up
- (2010) Lisa Rydén et al. BREAST CANCER RESEARCH AND TREATMENT
- Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies
- (2010) I Goldstein et al. CANCER GENE THERAPY
- Triple-Negative Breast Cancer
- (2010) Ayca Gucalp et al. CANCER JOURNAL
- The Mitotic Kinase Aurora-A Induces Mammary Cell Migration and Breast Cancer Metastasis by Activating the Cofilin-F-actin Pathway
- (2010) L.-h. Wang et al. CANCER RESEARCH
- The High Mobility Group A1 Gene: Transforming Inflammatory Signals into Cancer?
- (2010) L. M.S. Resar CANCER RESEARCH
- Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor
- (2010) H. Harrison et al. CANCER RESEARCH
- Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway
- (2010) Zhijian Du et al. CANCER SCIENCE
- p53-family proteins and their regulators: hubs and spokes in tumor suppression
- (2010) L Collavin et al. CELL DEATH AND DIFFERENTIATION
- Targeting tumour-initiating cells to improve the cure rates for triple-negative breast cancer
- (2010) Anna L. Stratford et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer
- (2010) Fusanori Yotsumoto et al. INTERNATIONAL JOURNAL OF CANCER
- MUC1 regulates nuclear localization and function of the epidermal growth factor receptor
- (2010) B. G. Bitler et al. JOURNAL OF CELL SCIENCE
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells
- (2010) K-F Chen et al. ONCOGENE
- Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
- (2010) N Turner et al. ONCOGENE
- Analysis of Kinase Gene Expression Patterns across 5681 Human Tissue Samples Reveals Functional Genomic Taxonomy of the Kinome
- (2010) Sami Kilpinen et al. PLoS One
- Is Expression or Activation of Src Kinase Associated with Cancer-Specific Survival in ER-, PR- and HER2-Negative Breast Cancer Patients?
- (2009) Beatrix Elsberger et al. AMERICAN JOURNAL OF PATHOLOGY
- High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy
- (2009) D. Trere et al. ANNALS OF ONCOLOGY
- Expression of androgen receptors in primary breast cancer
- (2009) S. Park et al. ANNALS OF ONCOLOGY
- Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells
- (2009) Oliver Treeck et al. BREAST CANCER RESEARCH AND TREATMENT
- Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion
- (2009) J Chen et al. BRITISH JOURNAL OF CANCER
- Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling
- (2009) Christina Gewinner et al. CANCER CELL
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
- (2009) Maddalena Adorno et al. CELL
- CIP2A Is Associated with Human Breast Cancer Aggressivity
- (2009) C. Come et al. CLINICAL CANCER RESEARCH
- Role of ADAMs in Cancer Formation and Progression
- (2009) M. J. Duffy et al. CLINICAL CANCER RESEARCH
- MicroRNA Gene Networks in Oncogenesis
- (2009) Alexandra Drakaki et al. CURRENT GENOMICS
- HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells
- (2009) Kozo Nakai et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type
- (2009) Britta Weigelt et al. JOURNAL OF PATHOLOGY
- Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
- (2009) Leo A Niemeier et al. MODERN PATHOLOGY
- Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the “Basal” Breast Cancer Subgroup
- (2009) M. Chehani Alles et al. PLoS One
- Elevating the frequency of chromosome mis-segregation as a strategy to kill tumor cells
- (2009) Aniek Janssen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis
- (2009) D. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Src in breast cancer
- (2008) R. S. Finn ANNALS OF ONCOLOGY
- Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers
- (2008) Tatsuya Toyama et al. BMC CANCER
- Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers
- (2008) Maria M Litwiniuk et al. BMC CANCER
- Pattern of metastatic spread in triple-negative breast cancer
- (2008) Rebecca Dent et al. BREAST CANCER RESEARCH AND TREATMENT
- Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
- (2008) J. H. Law et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Nuclear and Cytoplasmic Expression of ER 1, ER 2, and ER 5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients
- (2008) A. M. Shaaban et al. CLINICAL CANCER RESEARCH
- Expression of Aurora A (but Not Aurora B) Is Predictive of Survival in Breast Cancer
- (2008) Y. Nadler et al. CLINICAL CANCER RESEARCH
- Targeting AMPK: A new therapeutic opportunity in breast cancer
- (2008) Sirwan M. Hadad et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- miR-126 Regulates Angiogenic Signaling and Vascular Integrity
- (2008) Jason E. Fish et al. DEVELOPMENTAL CELL
- Myc's broad reach
- (2008) M. Eilers et al. GENES & DEVELOPMENT
- Clinical and Pathologic Characteristics of Patients WithBRCA-Positive andBRCA-Negative Breast Cancer
- (2008) Deann P. Atchley et al. JOURNAL OF CLINICAL ONCOLOGY
- A Synthetic Lethal Therapeutic Approach: Poly(ADP) Ribose Polymerase Inhibitors for the Treatment of Cancers Deficient in DNA Double-Strand Break Repair
- (2008) Alan Ashworth JOURNAL OF CLINICAL ONCOLOGY
- ERBB3/HER3 and ERBB2/HER2 Duet in Mammary Development and Breast Cancer
- (2008) David F. Stern JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target
- (2008) George P. Skliris et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The ins and outs of GPR30: A transmembrane estrogen receptor
- (2008) Eric R. Prossnitz et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- Estrogen and its receptors in cancer
- (2008) George G Chen et al. MEDICINAL RESEARCH REVIEWS
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
- The RSK family of kinases: emerging roles in cellular signalling
- (2008) Rana Anjum et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Successful Inhibition of Tumor Development by Specific Class-3 Semaphorins Is Associated with Expression of Appropriate Semaphorin Receptors by Tumor Cells
- (2008) Boaz Kigel et al. PLoS One
- Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
- (2008) J. A. Foekens et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The utility of LNA in microRNA-based cancer diagnostics and therapeutics
- (2008) Jan Stenvang et al. SEMINARS IN CANCER BIOLOGY
- ERβ in breast cancer—Onlooker, passive player, or active protector?
- (2008) Emily M. Fox et al. STEROIDS
- The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases
- (2007) Paul et al. Frontiers in Bioscience-Landmark
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now